VC-backed Gossamer Bio goes public
San Diego-based biopharmaceutical company Gossamer Bio has raised $276 million for its IPO after pricing its 17.25 million shares at $16 per share. The stock began trading February 8, 2019 on the NASDAQ under the ticker symbol "GOSS." BofA Merrill Lynch, SVB Leerink, Barclays and Evercore ISI are the lead underwriters. Gossamer's pre-IPO backers include Omega Funds and and ARCH Venture Partners.
8 February 2019•3 mins read
